 | • レポートコード：GIR-23F3904 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Prescription Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の処方薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 処方薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・先発医薬品、ジェネリック医薬品 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の処方薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 処方薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：先発医薬品、ジェネリック医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の処方薬市場規模・予測 - 世界の処方薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：先発医薬品、ジェネリック医薬品 ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・処方薬の北米市場分析 - 処方薬の北米市場：タイプ別市場規模2017年-2028年 - 処方薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・処方薬のヨーロッパ市場分析 - ：処方薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：処方薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・処方薬のアジア太平洋市場分析 - 処方薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 処方薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・処方薬の南米市場分析 - 処方薬の南米市場：タイプ別市場規模2017年-2028年 - 処方薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・処方薬の中東・アフリカ市場分析 - 処方薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 処方薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prescription Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Prescription Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brand Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prescription Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, and Merck & Co. (MSD), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prescription Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Brand Drugs
Generic Drug
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Prescription Drugs market are listed below:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Drugs, with price, sales, revenue and global market share of Prescription Drugs from 2019 to 2022.
Chapter 3, the Prescription Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prescription Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Drugs.
Chapter 13, 14, and 15, to describe Prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Prescription Drugs Market Size & Forecast
1.4.1 Global Prescription Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prescription Drugs Sales in Volume (2017-2028)
1.4.3 Global Prescription Drugs Price (2017-2028)
1.5 Global Prescription Drugs Production Capacity Analysis
1.5.1 Global Prescription Drugs Total Production Capacity (2017-2028)
1.5.2 Global Prescription Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Drugs Market Drivers
1.6.2 Prescription Drugs Market Restraints
1.6.3 Prescription Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Prescription Drugs Product and Services
2.1.4 Pfizer Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Prescription Drugs Product and Services
2.2.4 Roche Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Prescription Drugs Product and Services
2.3.4 Sanofi Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Prescription Drugs Product and Services
2.4.4 Johnson & Johnson Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Prescription Drugs Product and Services
2.5.4 Merck & Co. (MSD) Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Prescription Drugs Product and Services
2.6.4 Novartis Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Prescription Drugs Product and Services
2.7.4 AbbVie Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Prescription Drugs Product and Services
2.8.4 Gilead Sciences Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Prescription Drugs Product and Services
2.9.4 GlaxoSmithKline (GSK) Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Prescription Drugs Product and Services
2.10.4 Amgen Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Prescription Drugs Product and Services
2.11.4 AstraZeneca Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Prescription Drugs Product and Services
2.12.4 Bristol-Myers Squibb Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Prescription Drugs Product and Services
2.13.4 Eli Lilly Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Prescription Drugs Product and Services
2.14.4 Teva Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Prescription Drugs Product and Services
2.15.4 Bayer Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Prescription Drugs Product and Services
2.16.4 Novo Nordisk Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Allergan
2.17.1 Allergan Details
2.17.2 Allergan Major Business
2.17.3 Allergan Prescription Drugs Product and Services
2.17.4 Allergan Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Prescription Drugs Product and Services
2.18.4 Takeda Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Prescription Drugs Product and Services
2.19.4 Boehringer Ingelheim Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Prescription Drugs Product and Services
2.20.4 Takeda Prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prescription Drugs Breakdown Data by Manufacturer
3.1 Global Prescription Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prescription Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prescription Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Prescription Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Prescription Drugs Manufacturer Market Share in 2021
3.5 Global Prescription Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prescription Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prescription Drugs Market Size by Region
4.1.1 Global Prescription Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Prescription Drugs Revenue by Region (2017-2028)
4.2 North America Prescription Drugs Revenue (2017-2028)
4.3 Europe Prescription Drugs Revenue (2017-2028)
4.4 Asia-Pacific Prescription Drugs Revenue (2017-2028)
4.5 South America Prescription Drugs Revenue (2017-2028)
4.6 Middle East and Africa Prescription Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prescription Drugs Sales in Volume by Type (2017-2028)
5.2 Global Prescription Drugs Revenue by Type (2017-2028)
5.3 Global Prescription Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prescription Drugs Sales in Volume by Application (2017-2028)
6.2 Global Prescription Drugs Revenue by Application (2017-2028)
6.3 Global Prescription Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prescription Drugs Sales by Type (2017-2028)
7.2 North America Prescription Drugs Sales by Application (2017-2028)
7.3 North America Prescription Drugs Market Size by Country
7.3.1 North America Prescription Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Prescription Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prescription Drugs Sales by Type (2017-2028)
8.2 Europe Prescription Drugs Sales by Application (2017-2028)
8.3 Europe Prescription Drugs Market Size by Country
8.3.1 Europe Prescription Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Prescription Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prescription Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Prescription Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Prescription Drugs Market Size by Region
9.3.1 Asia-Pacific Prescription Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prescription Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prescription Drugs Sales by Type (2017-2028)
10.2 South America Prescription Drugs Sales by Application (2017-2028)
10.3 South America Prescription Drugs Market Size by Country
10.3.1 South America Prescription Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Prescription Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prescription Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Prescription Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Prescription Drugs Market Size by Country
11.3.1 Middle East & Africa Prescription Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prescription Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prescription Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prescription Drugs
12.3 Prescription Drugs Production Process
12.4 Prescription Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prescription Drugs Typical Distributors
13.3 Prescription Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Prescription Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Prescription Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Prescription Drugs Product and Services
Table 6. Pfizer Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Prescription Drugs Product and Services
Table 10. Roche Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Prescription Drugs Product and Services
Table 14. Sanofi Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Prescription Drugs Product and Services
Table 18. Johnson & Johnson Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. (MSD) Major Business
Table 21. Merck & Co. (MSD) Prescription Drugs Product and Services
Table 22. Merck & Co. (MSD) Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Prescription Drugs Product and Services
Table 26. Novartis Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AbbVie Basic Information, Manufacturing Base and Competitors
Table 28. AbbVie Major Business
Table 29. AbbVie Prescription Drugs Product and Services
Table 30. AbbVie Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Major Business
Table 33. Gilead Sciences Prescription Drugs Product and Services
Table 34. Gilead Sciences Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline (GSK) Major Business
Table 37. GlaxoSmithKline (GSK) Prescription Drugs Product and Services
Table 38. GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Prescription Drugs Product and Services
Table 42. Amgen Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Prescription Drugs Product and Services
Table 46. AstraZeneca Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb Prescription Drugs Product and Services
Table 50. Bristol-Myers Squibb Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Prescription Drugs Product and Services
Table 54. Eli Lilly Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Teva Basic Information, Manufacturing Base and Competitors
Table 56. Teva Major Business
Table 57. Teva Prescription Drugs Product and Services
Table 58. Teva Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Prescription Drugs Product and Services
Table 62. Bayer Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 64. Novo Nordisk Major Business
Table 65. Novo Nordisk Prescription Drugs Product and Services
Table 66. Novo Nordisk Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Prescription Drugs Product and Services
Table 70. Allergan Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Prescription Drugs Product and Services
Table 74. Takeda Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Prescription Drugs Product and Services
Table 78. Boehringer Ingelheim Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Takeda Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Major Business
Table 81. Takeda Prescription Drugs Product and Services
Table 82. Takeda Prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Prescription Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Prescription Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Prescription Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Prescription Drugs Production Site of Key Manufacturer
Table 88. Prescription Drugs New Entrant and Capacity Expansion Plans
Table 89. Prescription Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Global Prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Global Prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Global Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Global Prescription Drugs Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Prescription Drugs Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Prescription Drugs Price by Type (2017-2022) & (USD/Unit)
Table 99. Global Prescription Drugs Price by Type (2023-2028) & (USD/Unit)
Table 100. Global Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Global Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Global Prescription Drugs Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Prescription Drugs Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Prescription Drugs Price by Application (2017-2022) & (USD/Unit)
Table 105. Global Prescription Drugs Price by Application (2023-2028) & (USD/Unit)
Table 106. North America Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 107. North America Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 108. North America Prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 111. North America Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 112. North America Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 113. North America Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Europe Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 115. Europe Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 116. Europe Prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Europe Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Europe Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Europe Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 130. South America Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 131. South America Prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 132. South America Prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 135. South America Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 136. South America Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 137. South America Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 146. Prescription Drugs Raw Material
Table 147. Key Manufacturers of Prescription Drugs Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Prescription Drugs Typical Distributors
Table 151. Prescription Drugs Typical Customers
List of Figures
Figure 1. Prescription Drugs Picture
Figure 2. Global Prescription Drugs Revenue Market Share by Type in 2021
Figure 3. Brand Drugs
Figure 4. Generic Drug
Figure 5. Global Prescription Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Prescription Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Prescription Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Prescription Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Prescription Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Prescription Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Prescription Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Prescription Drugs Market Drivers
Figure 16. Prescription Drugs Market Restraints
Figure 17. Prescription Drugs Market Trends
Figure 18. Global Prescription Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Prescription Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Prescription Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Prescription Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Prescription Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Prescription Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Prescription Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Prescription Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Prescription Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Prescription Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Prescription Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Prescription Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Prescription Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Prescription Drugs in 2021
Figure 77. Manufacturing Process Analysis of Prescription Drugs
Figure 78. Prescription Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source